Tutorials
Exelixis Inc logo

Exelixis Inc

$ 21.06 -0.49 (-2.27%) 10:08 PM EST
P/E:
22.89
P/B:
2.94
Market Cap:
$ 6.75B
Enterprise V:
$ 5.24B
Volume:
3.77M
Avg Vol (2M):
2.48M
Also Trade In:
Volume:
3.77M
Market Cap $:
6.75B
PE Ratio:
22.89
Avg Vol (2-Month):
2.48M
Enterprise Value $:
5.24B
PB Ratio:
2.94
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Exelixis Inc
NAICS : 541714 SIC : 8731
1851 Harbor Bay Parkway, Alameda, CA, USA, 94502
Description
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Financials (Next Earnings Date:2022-08-09)

EXEL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:EXEL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,520.72
EPS (TTM) ($) 0.92
Beta 0.39
Volatility % 41.53
14-Day RSI 48.98
14-Day ATR ($) 0.697345
20-Day SMA ($) 21.3315
12-1 Month Momentum % 25.41
52-Week Range ($) 15.5 - 23.4
Shares Outstanding (Mil) 320.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Exelixis Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More